Drug Shortage Report for PMS-TADALAFIL

Last updated on 2020-06-03 History
Report ID 64838
Drug Identification Number 02409445
Brand name PMS-TADALAFIL
Common or Proper name TADALAFIL
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-17
Estimated end date 2020-01-03
Actual end date 2020-06-02
Shortage status Resolved
Updated date 2020-06-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-06-03 French Compare
v11 2020-06-03 English Compare
v10 2019-11-15 French Compare
v9 2019-11-15 English Compare
v8 2019-06-28 French Compare
v7 2019-06-28 English Compare
v6 2019-01-16 French Compare
v5 2019-01-16 English Compare
v4 2019-01-16 French Compare
v3 2019-01-16 English Compare
v2 2018-10-19 French Compare
v1 2018-10-19 English Compare

Showing 1 to 12 of 12